Healthy Minds With Dr. Jeffrey Borenstein
Alzheimer’s Disease: Diagnosis & Treatment
New advances in blood tests for biomarkers mean earlier diagnosis and defined categories of Alzheimer’s disease enabling doctors to delay onset of symptoms, with lower costs to patients and higher accuracy. Guest:Howard Fillit, M.D., Co-Founder and Chief Science Officer, Alzheimer’s Drug Discovery Foundation.
